Objective: To explore the National Survey of Drug Information Centers practice in Saudi Arabia: PharmacoEconomic System at Ministry of Health Hospitals. Methods: It is a crosssectional four months national survey of Drug Information Services at MOH. It contained ten domains with 181 questions designed by the authors. It was derived from Internal Pharmaceutical Federation (FIP), American Society of Health-System Pharmacists best practice guidelines. This survey was distributed to forty hospital pharmacies that run drug information services. In this study, the domain of Pharmacoeconomics System was explored and analyzed. It consisted of eight questions about the written policy and procedure and application methods for the PharmacoEconomic system in the drug information centers. All analysis was done through survey monkey system. Results: The survey was distributed to forty-five of hospitals, the response rate, was 40 (88.88%) hospitals. Of those; The Written policy and procedure of PharmacoEconomic did not exist in 26 (65%) hospitals. The definition types of PharmacoEconomic do not exist in 23 (57.5%) hospitals. Evaluation Processes of PharmacoEconomic Studies did not exist in 22 (55%) hospitals. The intensive analysis performed for all significant potential cost of the medications did not exist in 22(55%) hospitals. The evidence for using reported PharmacoEconomic data to improve medication use process and reduce cost rate, not found in 22 (55%) hospitals. Moreover, the Evidence of involvement of Drug Evaluation Processes not existed in 20 (50%) hospitals. Conclusion: the pharmacoeconomics system was week implementations of drug information centers practice. Revision of pharmacy strategic plan with pharmacoeconomics applications is required to improve the system at MOH hospital in the kingdom of Saudi Arabia.
INTRODUCTION
The fifth strategic goal of pharmacy plan of MOH organization in the kingdom of Saudi Arabia was the utilization of best resource based on Pharmacoeconomic [1] . Also, the pharmacoeconomics tools as measuring indicators of several pharmacy practices and clinical pharmacy programs including but not limited to the Pharmacy pain management program, pharmacy anticoagulation program and antimicrobial stewardship program [2] [3] [4] . Several published literature discussed Pharmacoeconomic in Saudi Arabia including pharmacy and Therapeutic committee [5] [6] [7] [8] [9] . Another study locally implemented Pharmacoeconomic in their studies as cost avoidance and impact. Calculation [10] [11] [12] . Some international studies discussed the pharmacoeconomics as part of drug information centers activities [13] [14] . There are not any local studies investigated the pharmacoeconomics concept used in drug information centers [15] . The authors are not familiar with any studies in Saudi Arabia or Gulf, Middle East, or rest if the world investigated the pharmacoeconomics system with such detail at group or network of drug information centers. The objective of the study was to explore the Pharmacoeconomic system at drug information centers of ministry of health hospitals.
METHODS
It is a national survey of Drug Information Services at MOH. It contained ten domains; Leadership and Practice Management, Medication Addition and Deletion System, Hospital Formulary System, Medication Safety System, Professional, and Public Education. The Evidence-Based Medicine-Therapeutics Guidelines (EBM-TG), Medication-Use Evaluation, Pharmacoeconomics System, Investigational Drug Services (IDS) and Professional Publications Services (PPPS), and Ethical and Legal Issue. It consisted of 181 questions designed by the authors. It drove from Internal Pharmaceutical Federation (FIP), American Society of Health-System Pharmacists best practice guidelines, the international standard of Joint Commission of Hospital Accreditation in addition to the local standards of Saudi center of health care accreditation and minimum standards of drug information centers in Saudi Arabia [16] [17] [18] [19] [20] . This survey was distributed to forty-five hospital pharmacies that run drug information services. The information of hospitals services taken from extensive records of General Administration of pharmaceutical care. In this study, the domain Pharmacoeconomics System was explored and analyzed. It contained eight question about the written policy and procedure for the PharmacoEconomic system that's included the definition types of PharmacoEconomic Analysis in drug information center and Evaluation Processes of PharmacoEconomic were studied. The intensive analysis was performed for all significant potential cost of the medications. Evidence for using reported PharmacoEconomic data to improve medication use process and reduce cost rate, Proof of involvement of Drug Evaluation Processes, Method for improving PharmacoEconomic Analysis in drug information centers (DIC), Evidence of reporting PharmacoEconomic Analysis in DIC were studied. All analysis was done through survey monkey system.
RESULTS
The survey was distributed to 45 hospitals, the response rate, was 40 (88.88%) hospitals. Of that 35 % large hospitals, 37.5 % medium size hospitals, 17.5 % small size hospitals, and 10 % National and Regional Drug Information Centers. OF those, fifteen hospitals were only accredited by CIBAHI and eight hospitals only accredited by Joint commission while none of them were accredited by ASHP or Canada. The majority of responders were Saudi 38 (95%), and 28 (70%) were male gender, and 12 (30%) were female as explored in table 1. Of responded hospitals, The Written policy and procedure of PharmacoEconomic did not exist in 26 (65%) hospitals while only three (7.5%) of hospitals 100% applied the elements. The Definition types of PharmacoEconomic Analysis do not exist in 23 (57.5%) hospitals while only five (12.5%) of hospitals applied 100% the elements. Evaluation Processes of PharmacoEconomic Studies did not exist in 22 (55%) hospitals while only four (10%) of hospital ultimately used the elements. The intensive analysis was performed for all significant potential cost of the medications did not exist in 22(55%) hospitals while only 3 (7.5%) of hospitals applied 100% elements. The evidence for using reported PharmacoEconomic data to improve medication use process and reduce cost rate, not found in 22 (55%) hospitals while only 3 (7.5%) of hospitals applied 100% elements. The Evidence of involvement of Drug Evaluation Processes was not existed in 20 (50%) hospitals while only four (10%) hospitals applied 100% elements. The method for improving PharmacoEconomic Analysis did not exist in 22 (55%) hospitals while only four (10%) hospitals applied 100% elements. The Evidence of reporting PharmacoEconomic Analysis in Drug formation practice does not exist in 22 (55%) hospitals while only 3 (7.5%) hospitals ultimately apply 100% of the elements as explored in table 2.
DISCUSSION
The ministry of health released health care strategic planning in 2010, with documented achievement [21] . [14, 24] . The findings were expected due to the system is newly founded at MOH hospital pharmacies and difficult to find an expert or qualified pharmacoeconomic pharmacist. The other finding was difficult to compare with them because it not mentioned at any drug information centers investigation. The pharmacoeconomic system needs very comprehensive education and training for drug information pharmacists, involve the system in the drug evaluation process of addition and deletion of medicines from MOH hospital formulary in addition to close monitoring and follow-up during implementation, the system at drug information centers of MOH hospitals in Kingdom of Saudi Arabia.
CONCLUSION
There was an indigent application of pharmacoeconomics system in drug information centers practice. An educating and training of drug information pharmacist on the pharmacoeconomic system and implementation of this scheme improves the applications of Pharmacoeconomics concept. It improves drug information services, chose the best cost-effective formulary medications, and avoids the unnecessary additional cost.
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